Acumen Pharmaceuticals Inc (ABOS)
3.36
-0.21
(-5.88%)
USD |
NASDAQ |
May 10, 16:00
3.36
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Enterprise Value: -14.32M for May 10, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 10, 2024 | -14.32M |
| May 09, 2024 | -1.700M |
| May 08, 2024 | -11.91M |
| May 07, 2024 | -14.32M |
| May 06, 2024 | -2.301M |
| May 03, 2024 | -6.506M |
| May 02, 2024 | -7.107M |
| May 01, 2024 | -20.93M |
| April 30, 2024 | -22.73M |
| April 29, 2024 | -25.13M |
| April 26, 2024 | -25.73M |
| April 25, 2024 | -24.53M |
| April 24, 2024 | -25.13M |
| April 23, 2024 | -26.33M |
| April 22, 2024 | -28.14M |
| April 19, 2024 | -26.93M |
| April 18, 2024 | -26.33M |
| April 17, 2024 | -7.708M |
| April 16, 2024 | -5.906M |
| April 15, 2024 | -4.103M |
| April 12, 2024 | 8.514M |
| April 11, 2024 | 17.53M |
| April 10, 2024 | 6.711M |
| April 09, 2024 | 14.52M |
| April 08, 2024 | 17.53M |
| Date | Value |
|---|---|
| April 05, 2024 | 15.12M |
| April 04, 2024 | 14.52M |
| April 03, 2024 | 18.73M |
| April 02, 2024 | 11.52M |
| April 01, 2024 | 24.74M |
| March 28, 2024 | 27.14M |
| March 27, 2024 | 30.14M |
| March 26, 2024 | 9.114M |
| March 25, 2024 | 39.15M |
| March 22, 2024 | 42.16M |
| March 21, 2024 | 43.96M |
| March 20, 2024 | 33.15M |
| March 19, 2024 | 15.46M |
| March 18, 2024 | 14.30M |
| March 15, 2024 | 25.88M |
| March 14, 2024 | 20.67M |
| March 13, 2024 | 35.73M |
| March 12, 2024 | 22.41M |
| March 11, 2024 | 31.67M |
| March 08, 2024 | 36.88M |
| March 07, 2024 | 36.88M |
| March 06, 2024 | 41.52M |
| March 05, 2024 | 35.73M |
| March 04, 2024 | 43.25M |
| March 01, 2024 | 52.52M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-107.72M
Minimum
Nov 09 2023
742.25M
Maximum
Jul 06 2021
105.15M
Average
38.87M
Median
Enterprise Value Benchmarks
| Accuray Inc | 273.70M |
| Kezar Life Sciences Inc | -135.05M |
| Akoya Biosciences Inc | 201.71M |
| NovaBay Pharmaceuticals Inc | 2.377M |
| Palatin Technologies Inc | 27.47M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.50M |
| Total Expenses (Quarterly) | 18.49M |
| EPS Diluted (Quarterly) | -0.29 |
| Earnings Yield | -32.44% |